← Back to Search

Mentoring for Cardiovascular Health

N/A

Recruiting

Research Sponsored by Northwestern University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Must not have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change in homa-ir score from baseline to approximately 1 year later

Awards & highlights

No Placebo-Only Group

Summary

This trial will test whether having a mentor can improve cardiovascular health for both the mentor and mentee.

Who is the study for?

This trial is for undergraduate students who can serve as mentors and Chicago Public School students eligible to be mentees. It aims to explore if mentor-mentee relationships positively affect cardiovascular health.

What is being tested?

The study tests the impact of interpersonal relationships on heart health by randomly assigning participants to either a mentoring role or providing them with written materials about cardiovascular wellness.

What are the potential side effects?

Since this trial involves social interaction rather than medical treatment, traditional side effects are not applicable. However, participants may experience emotional or psychological impacts from the mentorship experience.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I'm sorry, I cannot provide a summary without the criterion. Please provide me with the criterion so that I can assist you better.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline to approximately 1 year later

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline to approximately 1 year later

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to approximately 1 year later for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Flow-mediated vasodilation

HOMA-IR

Metabolic symptoms

Secondary study objectives

Glucocorticoid sensitivity

Pro-inflammatory cytokines

Stimulated cytokine production

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention (Mentor/Mentee)Experimental Treatment1 Intervention

Youth in the intervention group will participate in one-on-one mentoring sessions (between mentors and mentees) once per week after school. Mentoring sessions will focus on social relationships, coping behaviors, and healthy lifestyles.

Group II: Comparison group - written materialsActive Control1 Intervention

Youth in the comparator group will receive written versions of all materials covered in the mentoring sessions.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Mentoring

2016

N/A

~420

0 / 1Eligibility criteria met